These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670 [TBL] [Abstract][Full Text] [Related]
3. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321 [TBL] [Abstract][Full Text] [Related]
4. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124 [TBL] [Abstract][Full Text] [Related]
5. EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy. Comabella M; Kakalacheva K; Río J; Münz C; Montalban X; Lünemann JD Mult Scler; 2012 May; 18(5):605-9. PubMed ID: 22020417 [TBL] [Abstract][Full Text] [Related]
6. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296 [TBL] [Abstract][Full Text] [Related]
7. Antiviral immune response in patients with multiple sclerosis and healthy siblings. Comabella M; Montalban X; Horga A; Messmer B; Kakalacheva K; Strowig T; Caballero E; Münz C; Lünemann J Mult Scler; 2010 Mar; 16(3):355-8. PubMed ID: 20203149 [TBL] [Abstract][Full Text] [Related]
8. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study. Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076 [TBL] [Abstract][Full Text] [Related]
9. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621 [TBL] [Abstract][Full Text] [Related]
10. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750 [TBL] [Abstract][Full Text] [Related]
11. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765 [TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients. Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis. Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676 [TBL] [Abstract][Full Text] [Related]